- Home
- SLM vs MMSI Comparison
SLM vs MMSI Comparison
Compare SLM & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLM
- MMSI
- Stock Information
- Founded
- SLM 1972
- MMSI 1987
- Country
- SLM United States
- MMSI United States
- Employees
- SLM N/A
- MMSI N/A
- Industry
- SLM Finance: Consumer Services
- MMSI Medical/Dental Instruments
- Sector
- SLM Finance
- MMSI Health Care
- Exchange
- SLM Nasdaq
- MMSI Nasdaq
- Market Cap
- SLM 7.2B
- MMSI 5.8B
- IPO Year
- SLM N/A
- MMSI 1990
- Fundamental
- Price
- SLM $32.37
- MMSI $95.03
- Analyst Decision
- SLM Buy
- MMSI Buy
- Analyst Count
- SLM 11
- MMSI 9
- Target Price
- SLM $31.55
- MMSI $109.11
- AVG Volume (30 Days)
- SLM 2.0M
- MMSI 611.3K
- Earning Date
- SLM 07-23-2025
- MMSI 04-24-2025
- Dividend Yield
- SLM 1.61%
- MMSI N/A
- EPS Growth
- SLM N/A
- MMSI 17.19
- EPS
- SLM 2.78
- MMSI 2.04
- Revenue
- SLM $1,449,130,000.00
- MMSI $1,388,357,000.00
- Revenue This Year
- SLM $7.60
- MMSI $11.31
- Revenue Next Year
- SLM $9.61
- MMSI $6.09
- P/E Ratio
- SLM $11.63
- MMSI $46.61
- Revenue Growth
- SLM N/A
- MMSI 8.19
- 52 Week Low
- SLM $19.39
- MMSI $80.02
- 52 Week High
- SLM $34.55
- MMSI $111.45
- Technical
- Relative Strength Index (RSI)
- SLM 53.17
- MMSI 46.91
- Support Level
- SLM $32.52
- MMSI $93.86
- Resistance Level
- SLM $34.55
- MMSI $97.18
- Average True Range (ATR)
- SLM 0.83
- MMSI 1.85
- MACD
- SLM -0.22
- MMSI -0.20
- Stochastic Oscillator
- SLM 11.38
- MMSI 18.48
About SLM SLM Corporation
SLM Corp is an education solutions company. It business is to originate and service loans to students and their families to finance the cost of their education. The provide Private Education Loans to mean education loans to students or their families that are not made, insured, or guaranteed by any state or federal government.
About MMSI Merit Medical Systems Inc.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.